Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 353

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Superficial Venous Thrombosis and Venous Thromboembolism: A Large, Prospective Epidemiologic Study

Decousus, Hervé, Quéré, Isabelle, Presles, Emilie, Becker, François, Barrellier, Marie-Thérèse, Chanut, Myriam, Gillet, Jean-Luc, Guenneguez, Hervé, Leandri, Christine, Mismetti, Patrick, Pichot, Olivier, Leizorovicz, Alain, for the POST (Prospective Observational Superficial Thrombophlebitis) Study Group* · 2010 · Annals of Internal Medicine

Abstract

BACKGROUND: Superficial venous thrombosis (SVT) is perceived to have a benign prognosis. OBJECTIVE: To assess the prevalence of venous thromboembolism in patients with SVT and to determine the 3-month incidence of thromboembolic complications. DESIGN: National cross-sectional and prospective epidemiologic cohort study. (ClinicalTrials.gov registration number: NCT00818688) SETTING: French office- and hospital-based vascular medicine specialists. PATIENTS: 844 consecutive patients with symptomatic SVT of the lower limbs that was at least 5 cm on compression ultrasonography. MEASUREMENTS: Incidence of venous thromboembolism and extension or recurrence of SVT in patients with isolated SVT at presentation. RESULTS: Among 844 patients with SVT at inclusion (median age, 65 years; 547 women), 210 (24.9%) also had deep venous thrombosis (DVT) or symptomatic pulmonary embolism. Among 600 patients without DVT or pulmonary embolism at inclusion who were eligible for 3-month follow-up, 58 (10.2%) developed thromboembolic complications at 3 months (pulmonary embolism, 3 [0.5%]; DVT, 15 [2.8%]; extension of SVT, 18 [3.3%]; and recurrence of SVT, 10 [1.9%]), despite 540 patients (90.5%) having received anticoagulants. Risk factors for complications at 3 months were male sex, history of DVT or pulmonary embolism, previous cancer, and absence of varicose veins. LIMITATION: The findings are from a specialist referral setting, and the study was terminated before the target patient population was reached because of slow recruitment. CONCLUSION: A substantial number of patients with SVT exhibit venous thromboembolism at presentation, and some that do not can develop this complication in the subsequent 3 months. PRIMARY FUNDING SOURCE: GlaxoSmithKline, sanofi-aventis, and the Ministère Francais de la Santé et des Sports (Programme Hospitalier de Recherche Clinique).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7326/0003-4819-152-4-201002160-00006

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 353

Metadata

Authors
Decousus, H., Quéré, I., Presles, E., Becker, F., Barrellier, M.-T., Chanut, M., Gillet, J.-L., Guenneguez, H., Leandri, C., Mismetti, P., Pichot, O., Leizorovicz, A., & for the POST (Prospective Observational Superficial Thrombophlebitis) Study Group*
Venue
Annals of Internal Medicine
Published
2010-02-16
Volume
152
Issue
4
Pages
218-224
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2116451043
Cited by
353
References
17
FWCI
22.51
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Superficial Venous Thrombosis and Venous Thromboembolism: A Large, Prospective Epidemiologic Study. https://app.cochat.ai/papers/10.7326/0003-4819-152-4-201002160-00006
The paper
Decousus, H., Quéré, I., Presles, E., Becker, F., Barrellier, M.-T., Chanut, M., Gillet, J.-L., Guenneguez, H., Leandri, C., Mismetti, P., Pichot, O., Leizorovicz, A., & for the POST (Prospective Observational Superficial Thrombophlebitis) Study Group*. (2010). Superficial Venous Thrombosis and Venous Thromboembolism: A Large, Prospective Epidemiologic Study. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-152-4-201002160-00006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.